Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis

Digestive Surgery

Volumn 16, Issue 2, 1999, Pages 93-101

  Johnson, C D ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; LEXIPAFANT; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; HUMAN; MORTALITY; MULTIPLE ORGAN FAILURE; REVIEW;

EID: 0032916081     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018699     Document Type: Review

References (85)

1. Glasbrenner B, Adler G: Pathophysiology of acute pancreatitis. Hepatogastroenterology 1993;40:517-521.
2. Lerch MM, Adler G: Pathophysiology of acute pancreatitis. Dig Surg 1994;11:186-192.
3. Braganza J, Chaloner C: Acute pancreatitis. Curr Opin Anaesthesiol 1995;8:126-131.
4. Go VLW: Etiology and epidemiology of pancreatitis in the United States; in Bradley I (ed): Acute Pancreatitis: Diagnosis and Therapy. New York, Raven Press, 1994, pp 235-239.
5. Thompson JS, Bragg LE, Hodgson PE, Rikkers LF: Postoperative pancreatitis. Surg Gynecol Obstet 1988;167:377-380.
6. Stanten R, Frey CF: Pancreatitis after endoscopic retrograde cholangiopancreatography. Arch Surg 1990;125:1032-1034.
7. Bergholm U, Langman M, Rawlins M, et al: Drug-induced acute pancreatitis. Pharmacoepidemiol Drug Safety 1995;5:329-334.
8. Steer ML, Meldolesi J, Figarella C: Pancreatitis. The role of lysosomes. Dig Dis Sci 1984;29: 934-938.
9. Bradley EL: The necessity for a clinical classification of acute pancreatitis: The Atlanta System; in Bradley EL (ed): Acute Pancreatitis: Diagnosis and Therapy. New York, Raven Press, 1994, pp 27-32.
10. Mann DV, Hershman MJ, Hittinger R, Glazer G: Multicentre audit of death from acute pancreatitis. Br J Surg 1994;81:890-3.11.
11. Heath D, Alexander D, Wilson C, Larvin M, Imrie CW, McMahon MJ: Which complications of acute pancreatitis are most lethal? A prospective multi-centre clinical study of 719 episodes. Gut 1995;36:478.
12. Tran DD, Cuesta MA, Schneider AJ, Wesdorp RIC: Prevalence and prediction of multiple organ system failure and mortality in acute pancreatitis. J Crit Care 1993;8:145-153.
13. de Beaux AC, Palmer KR, Carter DC: Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut 1995;37:121-126.
14. Steinberg W, Tenner S: Acute pancreatitis. N Engl J Med 1994;330:1198-1210.
15. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. JAMA 1994;271:226-233.
16. Banerjee AK, Haggie SJ, Jones RB, Basran GS: Respiratory failure in acute pancreatitis. Postgrad Med 1995;71:327-330.
17. Pirotzky E, Page C, Morley J, et al: Vascular permeability induced by PAF-acether (platelet activating factor) in the isolated perfused rat kidney. Agents Actions 1985;16:7-18.
18. Braquet P, Poubert-Braquet M, Koltai M, et al: Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol Sci 1989;10:23-30.
19. Esplugues JV, Whittle BJR: Gastric mucosal damage induced by local intra-arterial administration of PAF in the rat. Br J Pharmacol 1988;93:222-228.
20. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN: Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996;83: 919-923.
21. de Beaux AC, Ross JA, Maingay JP, Fearon KCH, Carter DC: Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg 1996;83:1071-1075.
22. Gross V, Leser HG, Heinisch A, Schölmerich J: Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993;40:522-530.
23. Worthen GS, Seccombe JF, Clay KL, Guthrie LA, Johnston RB: The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor - potential role of mediation of enhanced superoxide secretion. J Immunol 1988;140:3553-3559.
24. Fujimura K, Kubota Y, Ogura M, et al: Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: Protective effects of a PAF-antagonist. J Gastroenterol Hepatol 1992;7:199-202.
25. Alonso R, Montero A, Arevalo M, et al: Platelet-activating factor mediates pancreatic function derangement in caerulein-induced pancreatitis in rats. Clin Sci 1994;87:85-90.
26. Imrie CW: Acute pancreatitis. Curr Opin Gastroenterol 1994;10:496-501.
27. Dabrowski A, Gabryelewicz A, Chyczewski L: The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress. Int J Pancreatol 1995;17:173-180.
28. Formela LJ, Galloway SW, Kingsnorth AN: Inflammatory mediators in acute pancreatitis. Br J Surg 1995;82:6-13.
29. Kingsnorth AN, Galloway SW, Formela LJ: Randomized, double-blind phase II trial of lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 1995;82: 1414-1420.
30. Konturek SJ, Dembinski A, Konturek PJ, et al: Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut 1992;33: 1268-1274.
31. Braquet P, Paubert-Braquet M, Bourgain RH, Bussolino F, Hosford D: PAF/cytokine autogenerated feedback networks in microvascular immune injury: Consequences in shock, ischemia and graft rejection. J Lipid Mediat 1989; 1:75-112.
32. Muirhead EE, Jones F, Stirman JA: Antihypertensive property in renoprival hypertension of extract from the renal medulla. J Lab Clin Med 1960;56:167-180.
33. Benveniste J, Henson PM, Cochrane CG: Leukocyte-dependent histamine release from rabbit platelets. J Exp Med 1972;136:1356-1377.
34. Benveniste J, Tencé M, Varenne P, Bidault J, Boullet C, Polonsky J: Semi-synthèse et structure proposée du facteur activant les plaquettes (PAF): PAF-acether, un alkyl ether analogue de la lysophosphatidylcholine. CR Acad Sci 1979; 289:1037-1040.
35. Demopoulos CA, Pinckard RN, Hanahan DJ: Platelet-activating factor. J Biol Chem 1979; 254:9355-9358.
36. Blank ML, Snyder F, Byers LW, Brooks B, Muirhead EE: Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem Biophys Res Commun 1979;90:1194-1200.
37. Snyder F: Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259: C697-C708.
38. Woodard DS, Lee T, Snyder F: The final step in the de novo biosynthesis of platelet-activating factor. J Biol Chem 1987;262:2520-2527.
39. Summers JB, Albert DH: Platelet activating factor antagonists. Adv Pharmacol 1995;32: 67-168.
40. 2. Scand J Gastroenterol 1996;31(suppl 219):24-27.
41. Camussi G, Bussolino F, Salvidio G, Baglioni C: Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987;166:1390-1404.
42. Chao W, Olson MS: Platelet-activating factor: Receptors and signal transduction. Biochem J 1993;292:617-629.
43. Valone FH, Coles E, Reinhold VR, Goetzl EJ: Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol 1982;129:1637-1641.
44. Kloprogge E, Akkerman JWN: Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J 1984;223(3):901-909.
45. Valone FH, Goetzl EJ: Specific binding by human polymorphonuclear leukocytes of the immunological mediator 1-O hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. Immunology 1983;48:141-149.
46. Bussolino F, Breviario F, Tetta C, Aglietta M, Mantovani A, Dejana E: Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest 1986;77:2027-2033.
47. O'Flaherty JT, Surles JR, Redman J, Jacobson D, Piantadosi C: Binding and metabolism of platelet-activating factor by human neutrophils. J Clin Invest 1986;78:381-388.
48. Valone FH: Identification of platelet-activating factor receptors in P388D1 murine macrophages. J Immunol 1988;140:2389-2334.
49. Liu H, Chao W, Olson MS: Regulation of the surface expression of the platelet-activating factor receptor in IC-21 peritoneal macrophages. Effects of lipopolysaccharide. J Biol Chem 1992;267:20811-20819.
50. Ng DS, Wong K: Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. Biochem Biophys Res Commun 1988;155:311-316.
51. Hwang SB, Lam MH, Shen TY: Specific binding sites for platelet activating factor in human lung tissues. Biochem Biophys Res Commun 1985;128:972-979.
52. Hwang SB: Specific receptor sites for platelet activating factor on rat liver plasma membranes. Arch Biochem Biophys 1987;257:339-344.
53. 3H) WEB 2086. Biochem Pharmacol 1989;38: 1702-1705.
54. Chao W, Liu H, Debuysere M, Hanahan DJ, Olson MS: Identification of receptors for platelet-activating factor in rat Kupffer cells. J Biol Chem 1989;264(23):13591-13598.
55. Sisson JH, Prescott SM, McIntyre TM, Zimmerman GA: Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. J Immunol 1987;138:3918-3926.
56. Prescott SM, Zimmerman GA, McIntyre TM: Platelet-activating factor. J Biol Chem 1990; 265:17381-17384.
57. O'Flaherty JT, Jacobson DP, Redman JF: Bidirectional effects of protein kinase C activators. Studies with human neutrophils and platelet-activating factor. J Biol Chem 1989;264:6836-6843.
58. 4 and platelet-activating factor and the responses they induce in neutrophils: Site of action. Proc Nat Acad Sci USA 1989;86: 5791-5794.
59. Kunz D, Gerard NP, Gerard C: The human leukocyte platelet-activating factor receptor. J Biol Chem 1992;267:9101-9106.
60. Shimizu T, Honda Z, Nakamura M, Bito H, Izumi T: PAF receptor and signal transduction. Biochem Pharmacol 1992;44:1001-1008.
61. Kald B, Kald A, Ihse I, Tagesson C: Release of platelet-activating factor in acute experimental pancreatitis. Pancreas 1993;8(4):440-442.
62. Zhou W, Levine BA, Olson MS: Platelet-activating factor: A mediator of pancreatic inflammation during cerulein hyperstimulation. Am J Pathol 1993;142(5):1504-1512.
63. Anderson BO, Bensard DD, Harken AH: The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 1991;172:415-424.
64. Emanuelli G, Montrucchio G, Dughera L, et al: Role of platelet activating factor in acute pancreatitis induced by lipopolysaccharides in rabbits. Eur J Pharmacol 1994;261:265-272.
65. Yotsumoto F, Manabe T, Kyogoku T, et al: Platelet-activating factor involvement in the aggravation of acute pancreatitis in rabbits. Digestion 1994;55:260-267.
66. Hirano T, Furuyama H, Tsuchitani P: Platelet activating factor (PAF) antagonist prevents impaired pancreatic blood flow in rabbits with caerulein-induced acute pancreatitis. Med Sci Res 1995;23:209-211.
67. Leonhardt U, Fayyazzi A, Seidensticker F, Stockmann F, Soling H, Creutzfeldt W: Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models. Int J Pancreatol 1992;12:161-166.
68. Zhou W, Levine BA, Olson MS: Lipid mediator production in acute and chronic pancreatitis in the rat. J Surg Res 1994;56:37-44.
69. Formela LJ, Wood LM, Whittaker M, Kingsnorth AN: Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. Br J Surg 1994;81:1783-1785.
70. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM: Endothelial cell-associated platelet-activating factor: A novel mechanism for signaling intercellular adhesion. J Cell Biol 1990;110:529-540.
71. Kortesuo PT, Nevalainen TJ, Büchler M, Uhl W: Characterization of two phospholipases A2 in serum of patients with sepsis and acute pancreatitis. Eur J Clin Chem Clin Biochem 1992; 30:263-269.
72. 2 in serum samples from patients with severe acute pancreatitis. Gut 1993;34:1133-1136.
73. Grönroos JM, Nevalainen TJ: Increased concentrations of synovial-type phospholipase A2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion 1992;52: 232-236.
74. Zimmerman GA, McIntyre TM, Prescott SM: Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest 1985;76:2235-2246.
75. Gross V, Schölmerich J, Leser HG, et al: Granulocyte elastase in assessment of severity of acute pancreatitis. Dig Dis Sci 1990;35:97-105.
76. Domínguez-Muñoz JE, Carballo F, Garcia MJ, et al: Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: The results of a multicentre study. Br J Surg 1991;78:1230-1234.
77. 4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Nat Acad Sci USA 1986;83:2204-2208.
78. Jancar S, De Giaccobi G, Mariano M, MenciaHuerta JM, Sirois P, Braquet P: Immune complex induced pancreatitis: Effect of BN-52021, a selective antagonist of platelet-activating factor. Prostaglandins 1988;35:757-770.
79. Dabrowski A, Gabryelewicz A, Chyczewski L: The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals. Int J Pancreatol 1991;8:1-11.
80. Jancar S, Abdo EE, Sampietre SN, et al: Effect of PAF antagonists on cerulein-induced pancreatitis. J Lipid Mediat Cell Signal 1995;11: 41-49.
81. Zhou W, McCollum MO, Levine BA, Olson MS: Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. Am J Pathol 1992;140:971-979.
82. Galloway SW, Kingsnorth AN: Acute lung injury in the microembolic model of acute pancreatitis (abstract). Digestion 1994;55:277.
83. Whittaker M, Askew M, Beauchamp CL, et al: Structure-activity relationships for BB-823 and related PAF-antagonists. J Lipid Mediat Cell Signal 1994;10:151-152.
84. McKay CJ, Curran FJ, Sharples C, Baxter JN, Imrie CW: Prospective placebo-controlled randomised trial of lexipafant in predicted severe acute pancreatitis. Br J Surg 1997;84:1239-1243.
85. Toh SKC, and the British Acute Pancreatitis Study Group: Lexipafant, a platelet activating factor (PAF) antagonist reduces mortality in a randomised placebo controlled study in patients with severe acute pancreatitis. Gut 1997; 40(suppl 1):A12.